Peripheral vascular endothelial dysfunction in glaucomatocyclitic crisis: A preliminary study

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 1, 2010, Pages 272-276

  Shen, Su Chin ^a   Ho, Wan Jing ^a   Wu, Shiu Chen ^a   Yu, Kuang Hui ^a   Lin, Hsin Chiung ^a   Lin, Yu Sheng ^a   Tsay, Pei Kwei ^b   Chu, Pao Hsien ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; HLA ANTIGEN; HOMOCYSTEINE; RO ANTIBODY; AUTOANTIBODY; CHOLESTEROL; GLYCERYL TRINITRATE; VASODILATOR AGENT;

ADULT; ARTERY DILATATION; ARTERY ENDOTHELIUM; BLOOD CELL COUNT; BLOOD PRESSURE; BODY MASS; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; GLAUCOMATOCYCLITIC CRISIS; HUMAN; INTRAOCULAR HYPERTENSION; IRITIS; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SMOKING; ADOLESCENT; ARTICLE; BLOOD; BLOOD FLOW; BLOOD FLOW VELOCITY; GLAUCOMA; GLUCOSE BLOOD LEVEL; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; LASER DOPPLER FLOWMETRY; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; AUTOANTIBODIES; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BLOOD PRESSURE; BRACHIAL ARTERY; CHOLESTEROL; ENDOTHELIUM, VASCULAR; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; NITROGLYCERIN; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; VASODILATOR AGENTS; YOUNG ADULT;

EID: 75749113782     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3849     Document Type: Review

References (35)

1. Posner A, Schlossman A. Syndrome of unilateral recurrent attacks of glaucoma with cyclitic symptoms. Arch Ophthalmol. 1948;39: 517-535.
2. Takahashi T, Ohtani S, Miyata K, Miyata N, Shirato S, Mochizuki M. A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol. 2002;46:556-562.
3. Puri P, Verma D. Bilateral glaucomatocyclitic crisis in a patient with Holmes Adie syndrome. J Postgrad Med. 1998;44:76-77.
4. Yamamoto S, Pavan-Langston D, Tada R, et al. Possible role of herpes simplex virus in the origin of Posner-Schlossman syndrome. Am J Ophthalmol. 1995;119:796-798.
5. Chee SP, Jap A. Presumed Fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegaloviruspositive and negative eyes. Am J Ophthalmol. 2008;146:883-889. e1.
6. Teoh SB, Thean L, Koay E. Cytomegalovirus in aetiology of Posner-Schlossman syndrome: evidence from quantitative polymerase chain reaction. Eye. 2005;19:1338-1340.
7. van Boxtel LA, van der Lelij A, van der Meer J, Los LI. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology. 2007;114:1358-1362.
8. Saccà SC, Pascotto A, Camicione P, Capris P, Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol. 2005;123:458-463.
9. Su WW, Cheng ST, Hsu TS, Ho WJ. Abnormal flow-mediated vasodilation in normal-tension glaucoma using a noninvasive determination for peripheral endothelial dysfunction. Invest Ophthalmol Vis Sci. 2006;47:3390-3394.
10. Su WW, Cheng ST, Ho WJ, Tsay PK, Wu SC, Chang SH. Glaucoma is associated with peripheral vascular endothelial dysfunction. Ophthalmology. 2008;115:1173-1178.
11. Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359-393.
12. Moens AL, Goovaerts I, Claeys MJ, Vrints CJ. Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest. 2005;127:2254-2263.
13. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;16; 39:257-265.
14. Park KH, Hong C. Reversal of optic disc topography in patients with glaucomatocyclitic crisis after remission of attack. J Glaucoma. 1998;7:225-229.
15. Irak I, Katz BJ, Zabriskie NA, Zimmerman PL. Posner-Schlossman syndrome and nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2003;23:264-267.
16. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-2207.
17. Wall RT, Harlan JM, Harker LA, Striker GE. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res. 1980;18:113-121.
18. Stamler JS, Osborne JA, Jaraki O, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;91:308-318.
19. Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C, Celermajer DS. Folic acid improves arterial endothelial function in adults with hyperhomocyst(e)inemia. J Am Coll Cardiol. 1999;34:2002-2006.
20. Pianka P, Almog Y, Man O, Goldstein M, Sela BA, Loewenstein A. Hyperhomocyst(e)inemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology. 2000;107:1588-1592.
21. Mielants H, Veys EM, Verbraeken H, De Vos M, Cuvelier C. HLAB27 positive idiopathic acute anterior uveitis: a unique manifestation of subclinical gut inflammation. J Rheumatol. 1990;17:841-842.
22. Chung YM, Liao HT, Lin KC, et al. Prevalence of spondyloarthritis in 504 Chinese patients with HLA-B27-associated acute anterior uveitis. Scand J Rheumatol. 2009;38:84-90.
23. Hirose S, Ohno S, Matsuda H. HLA-Bw54 and glaucomatocyclitic crisis. Arch Ophthalmol. 1985;103:1837-1839.
24. Monnet D, Breban M, Hudry C, Dougados M, Brézin AP. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology. 2004;111:802-809.
25. Bossuyt X, Frans J, Hendrickx A, Godefridis G, Westhovens R, Mariën G. Detection of anti-SSA antibodies by indirect immunofluorescence. Clin Chem. 2004;50:2361-2369.
26. Candon S, Gottenberg J, Bengoufa D, Chatenoud L, Mariette X. Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren's syndrome: correlation with B cell biomarkers and disease activity. Ann Rheum Dis. 2009;68(7):1208-1212.
27. Farmer-Boatwright MK, Roubey RA. Venous thrombosis in the antiphospholipid syndrome. Arterioscler Thromb Vasc Biol. 2009; 29:321-325.
28. Bilora F, Sartori MT, Zanon E, Campagnolo E, Arzenton M, Rossato A. Flow-mediated arterial dilation in primary antiphospholipid syndrome. Angiology. 2009;60:104-107.
29. Anderson EA, Mark AL. Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation. 1989;79:93-100.
30. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
31. Betik AC, Luckham VB, Hughson RL. Flow-mediated dilation in human brachial artery after different circulatory occlusion conditions. Am J Physiol Heart Circ Physiol. 2004;286:H442-H448.
32. McGowan CL, Levy AS, Millar PJ, et al. Acute vascular responses to isometric handgrip exercise and effects of training in persons medicated for hypertension. Am J Physiol Heart Circ Physiol. 2006;291:H1797-H1802.
33. Fenster BE, Tsao PS, Rockson SG. Endothelial dysfunction: clinical strategies for treating oxidant stress. Am Heart J. 2003;146:218-226.
34. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115: 1285-1295.
35. Sugiura T, Kondo T, Kureishi-Bando Y, et al. Nifedipine improves endothelial function: role of endothelial progenitor cells. Hypertension. 2008;52:491-498.